Loading...

Absci Corporation

ABSI•NASDAQ
Healthcare
Biotechnology
$3.98
$0.30(8.29%)
U.S. Market is Open • 11:24

Absci Corporation (ABSI) Stock Overview

Explore Absci Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap607.5M
P/E Ratio-5.12
EPS (TTM)$-0.84
ROE-0.60%
Fundamental Analysis

AI Price Forecasts

1 Month$0.98
3 Months$2.38
1 Year Target$2.55

ABSI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Absci Corporation (ABSI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.87, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.12 and a market capitalization of 607.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.88%
5-Day Change
19.22%
1-Month Change
35.49%
3-Month Change
36.43%
6-Month Change
-7.24%
Year-to-Date (YTD) Change
13.75%
1-Year Change
24.45%
3-Year Change
156.13%
5-Year Change
-81.61%
All-Time (Max) Change
-81.61%

Contact Information

https://www.absci.com
360 949 1041
18105 SE Mill Plain Boulevard, Vancouver, WA, 98683

Company Facts

156 Employees
IPO DateJul 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions